MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01709cam a2200289 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780128130735 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
201215t2021 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128130735 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dempster, David W. (ed) |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Marcus and Feldman's Osteoporosis. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
5th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Amsterdam |
| Name of publisher, distributor, etc. |
Academic Press |
| Date of publication, distribution, etc. |
2021 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Fifth edition / edited by David W. Dempster, Jane A. Cauley, Mary L. Bouxsein, Felicia Cosman. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Previous edition: published as Osteoporosis. 2013. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
text |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
still image |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
CIP record. Publication date: 10 2020 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Marcus and Feldman's Osteoporosis, Fifth Edition, is the most comprehensive, authoritative reference on this disease. Led by a new editorial team, this fifth edition offers critical information on reproductive and hormonal risk factors, new therapeutics, ethnicity, nutrition, therapeutics, management and economics, comprising a tremendous wealth of knowledge in a single source not found elsewhere. Written by renowned experts in the field, this two-volume reference is a must-have for biomedical researchers, research clinicians, fellows, academic and medical libraries, and any company involved in osteoporosis drug research and development. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
OSTEOPOROSIS |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
OSTEOPOROSIS, therapy |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cauley, Jane A. (ed) |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bouxsein, Mary L. (ed) |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cosman, Felicia [1958-] (ed) |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20161019259">https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20161019259</a> |
| Link text |
[E-boo,. Please log in using your NHS OpenAthens username and password] |